Show Summary Details
Page of

Proteus Syndrome 

Proteus Syndrome
Proteus Syndrome

Leslie G. Biesecker

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 25 February 2021

Proteus syndrome is a very rare mosaic overgrowth disorder that can affect most any tissue of the body, most commonly the skin, skeleton, vascular system, and adipose tissue. Most manifestations of Proteus syndrome are postnatal, with typical onset of overgrowth in the 6-24 month age range with relentless and distorting overgrowth that often abates at the end of puberty. This overgrowth can be mild, but more often causes major orthopedic and vascular complications. To date, all patients with Proteus syndrome have the same c.49G>A p.Glu17Lys somatic mosaic mutation in AKT1, with the mutation level ranging from <1% to almost 50% (nearly non-mosaic heterozygous). This mutation leads to constitutive activation of the transmembrane receptor-PIK3CA-AKT signal transduction cascade, which explains many of the manifestations of this disorder as the pathway transduces numerous growth factor signals.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.